Regeneron Drug Approved to Help Prevent Severe COVID in Vulnerable After Exposure
WEDNESDAY, Aug. 4, 2021 (HealthDay News) — A preventive monoclonal antibody injection for people at high risk for developing severe COVID-19 after exposure to the coronavirus has been approved by the U.S. Food and Drug Administration. The first dose of Regeneron’s cocktail must be injected within 96 hours of exposureContinue Reading